VIE/REC (VIE/REC)

Vienna Stock Exchange: VIE/REC · EUR

€53.0

-0.05 (-0.1%)· Recorded snapshot

Market cap	10.9B
Revenue (ttm)	2.7B
Net income (ttm)	497.2M
EPS (ttm)	€2.38
P/E (trailing)	22.3x
P/E (forward)	15.3x
Dividend	€1.34 (2.53%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.7B
Net income (ttm): 497.2M
EPS (ttm): €2.38
P/E (trailing): 22.3x
P/E (forward): 15.3x
Market cap: 10.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E15.3

P25 14.3P50 18.7P75 25.4

Trailing P/E22.3

P25 20.4P50 26.7P75 39.7

ROE24.9

P25 4.8P50 10.6P75 20.1

ROIC15.4

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/REC indicators

Market & fundamental data

Available fields

244

Groups with data

Currency

EUR

Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Italy
Country code	AT
Earnings date	2026-11-10
Employees	4,654
Employees change	110
Employees growth	2.4%
Enterprise value	EUR 12.8B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1926
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	IT0003828271
Last earnings date	2026-07-28
Last refreshed	2026-10-29
Market cap	EUR 10.9B
Next earnings date	2026-11-10
Price	EUR 53.00
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	vie/REC
Website	https://recordati.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	24.53x
Average P/E ratio (3Y)	24.72x
Average P/E ratio (5Y)	24.97x
Earnings yield	4.49%
EV/Earnings	25.7x
EV/EBIT	15.5x
EV/EBITDA	12.43x
EV/FCF	21.3x
EV/Sales	4.72x
FCF / EV yield	4.69%
FCF yield	5.53%
Forward P/E	15.3x
Graham number	23.83652
Graham upside	-55.03%
Lynch fair value	EUR 15.46
Lynch upside	-70.84%
P/(FCF - SBC) ratio	19.09x
P/(OCF - SBC) ratio	17.69x
P/B ratio	5.09x
P/E ratio	22.27x
P/FCF ratio	18.1x
P/OCF ratio	16.84x
P/S ratio	4.01x
Price/EBITDA ratio	10.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	30.47%
EBITDA margin	37.49%
Effective tax rate	24.54%
FCF margin	22.17%
Gross margin	71.48%
Operating margin	30.47%
Pretax margin	24.35%
Profit margin	18.38%
Profit per employee	EUR 106,828
Profitable quarters	70
Profitable years	23
Revenue per employee	EUR 581,289
ROA	9.77%
ROA (5Y)	9.94%
ROCE	20.77%
ROE	24.85%
ROE (5Y)	24.24%
ROIC	15.35%
ROIC (5Y)	16.25%
SBC / revenue	1.15%
Tax / revenue	5.98%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	22.23%
EPS growth (Q)	28.64%
EPS growth (QoQ)	-23.54%
EPS growth 10Y	8.59%
EPS growth 3Y	8.6%
EPS growth 5Y	6.39%
EPS growth quarters	3
EPS growth years	3
FCF growth	12.31%
FCF growth (Q)	111.86%
FCF growth (QoQ)	126.24%
FCF growth 3Y	7.63%
FCF growth 5Y	8.99%
Gross profit growth	9.52%
Gross profit growth (Q)	11.06%
Gross profit growth 3Y	10.22%
Gross profit growth 5Y	12.81%
Net income growth	22.08%
Net income growth (Q)	28.03%
Net income growth (QoQ)	-23.81%
Net income growth 3Y	8.57%
Net income growth 5Y	6.37%
Net income growth quarters	3
Net income growth years	3
OCF growth	12.13%
OCF growth (Q)	102.17%
OCF growth (QoQ)	111.03%
OCF growth 10Y	9.44%
OCF growth 3Y	8.34%
OCF growth 5Y	9.33%
Operating income growth	10.27%
Operating income growth (Q)	16.09%
Operating income growth 3Y	10.98%
Operating income growth 5Y	12.29%
Revenue growth	9.1%
Revenue growth (Q)	8.31%
Revenue growth (QoQ)	-2.25%
Revenue growth 10Y	9.45%
Revenue growth 3Y	10.5%
Revenue growth 5Y	13.14%
Revenue growth quarters	21
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -44.8M
Depreciation and amortization	EUR 189.8M
EBIT	EUR 824.3M
EBITDA	EUR 1B
EPS	EUR 2.38
Financing cash flow	EUR -493.3M
Free cash flow	EUR 599.9M
Free cash flow minus SBC	EUR 568.7M
Gross profit	EUR 1.9B
Income taxes	EUR 161.7M
Investing cash flow	EUR -115.4M
Net borrowing	EUR -176.3M
Net cash flow	EUR 49.8M
Net income	EUR 497.2M
Operating cash flow minus SBC	EUR 613.5M
Operating income	EUR 824.3M
Revenue	EUR 2.7B
Stock-based compensation	EUR 31.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.65
Book value per share	EUR 10.40
Debt / EBITDA	2.25
Debt / equity	1.09
Debt / FCF	3.86
Goodwill	EUR 806.4M
Interest coverage	8.46
Long-term assets	EUR 3.6B
Long-term liabilities	EUR 1.8B
Net cash (debt)	EUR -1.9B
Net cash / market cap	-17.71%
Net debt / EBITDA	1.9
Net debt / equity	0.9
Net debt / FCF	3.2
Piotroski F-Score	6
Property, plant and equipment	EUR 230.7M
Shareholders' equity	EUR 2.1B
Tangible book value	EUR -961.4M
Tangible book value per share	EUR -4.69
Total assets	EUR 5.4B
Total cash	EUR 391.4M
Total debt	EUR 2.3B
Total liabilities	EUR 3.2B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	EUR 1.8B
Current liabilities	EUR 1.4B
Current ratio	1.26
Inventory turnover	1.48
Net working capital	EUR 591.1M
Quick ratio	0.84
Working capital	EUR 358.9M
Working capital turnover	6.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.14%
Dividend growth	5.51%
Dividend growth (3Y)	5.23%
Dividend growth (5Y)	5%
Dividend growth years	9
Dividend payment date	2026-05-20
Dividend payment years	11
Dividend payout frequency	Semi-Annual
Dividend per share	EUR 1.34
Dividend yield	2.53%
Ex-dividend date	2026-05-18
Last dividend	EUR 0.71
Payout ratio	54.93%
Shareholder yield	2.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 51.52
1D price change	-0.09%
1M price change	-0.09%
1M total return	-0.09%
1W price change	-0.28%
1W total return	-0.28%
1Y price change	3.62%
1Y return CAGR	6.38%
1Y total return	6.37%
20-day SMA	EUR 52.97
200-day SMA	EUR 50.41
3M price change	3.11%
3M total return	3.11%
3Y price change	21.28%
3Y return CAGR	9.38%
3Y total return	30.88%
50-day SMA	EUR 52.76
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 54.15
52-week high date	2025-11-12
52-week low	EUR 43.98
52-week low date	2026-03-19
5Y price change	0.76%
5Y return CAGR	2.72%
5Y total return	14.34%
6M price change	6.81%
6M total return	8.3%
All-time high	EUR 60.25
All-time high date	2025-02-14
All-time low	EUR 27.59
All-time low date	2018-03-26
Average true range (ATR)	EUR 0.16
Average volume	0
Change from 52-week high	-2.12%
Change from 52-week low	20.51%
Change from all-time high	-12.03%
Change from all-time low	92.1%
Change from open	0.19%
Day's gap	-0.28%
High price	EUR 53.00
Low price	EUR 52.90
Monthly RSI	56.97
Open price	EUR 52.90
Position in 52-week range	100%
Previous close	EUR 53.05
Price vs 150-day SMA	2.87%
Price vs 20-day SMA	0.06%
Price vs 200-day SMA	5.14%
Price vs 50-day SMA	0.46%
Relative volume	160.91
RSI	53.66
Sharpe ratio	0.22
Sharpe ratio (3Y)	0.29
Sharpe ratio (5Y)	0.12
Sortino ratio	0.76
Sortino ratio (3Y)	0.66
Sortino ratio (5Y)	0.42
Weekly RSI	59.94
YTD price change	9.28%
YTD total return	10.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	101.9M
Shares change (QoQ)	-0.36%
Shares change (YoY)	-0.14%
Shares held by insiders	0.26%
Shares held by institutions	25.05%

Deeper analysis on VIE/REC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/REC report

Is a complete VIE/REC research report available?

No complete published report is available for vie/REC (VIE/REC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/REC (VIE/REC)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/REC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/REC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/REC

Frequently asked questions